Therapeutic efficacy of ketanserin, a selective antagonist of the serotonin (5-HT2) receptors, in primary and secondary Raynaud's phenomenon.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples